Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status shows no current enrollment; new guidance sections were added and header formatting updated, with a new revision tag (v3.6.0).SummaryDifference0.4%

- Check8 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new published revision of the page content. This change represents an update to the page's version metadata rather than a modification to the substantive study information.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision/version number was incremented from v3.5.2 to v3.5.3, reflecting a non-content site update.SummaryDifference0.1%

- Check58 days agoChange DetectedThe site revision has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded a link to the Genetic and Rare Diseases Information Center under Resources and updated the page revision to 3.5.0 (replacing 3.4.3).SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.